Rodon Biologics

Rodon Biologics

Rodon Biologics provides excellence in the development of biopharmaceutical products for third parties.

About the plant

About Us

Rodon Biologics, a leading biotech CRO/CDMO, has 20 years delivering protein solutions tailored for discovery research and beyond. The company specializes in engineering, producing, analyzing, and characterizing recombinant proteins, as well as small molecules derived from engineered microorganisms.

Rodon delivers comprehensive solutions—including processes, data, and products—tailored for discovery, early-stage research, preclinical development, and manufacturing. Established in 1999 as Biotecnol, the company initially focused on supporting the development of recombinant protein therapeutics and has since expanded its expertise and service offerings, specializing in cell-culture based development and production of proteins and other molecule types using engineered E.coli, Yeast, and Mammalian cells.

We have extensive experience in utilizing different expression systems for the production and purification of recombinant proteins. We support projects from the early stages of research and discovery to development and manufacturing for clinical trials. Our services encompass everything from DNA to drug product, allowing us to engineer, produce, and characterize products from a few milligrams to tens of grams for initial research. We further support ongoing development with stable cell line generation and a robust, scalable process, working in partnership with CMOs for GMP manufacturing during clinical trials.

Our mission is to empower innovation in biotechnology and life sciences by providing exceptional solutions for protein and small molecule production. We are dedicated to accelerating discovery, development, and manufacturing processes through our expertise, advanced technologies, and collaborative partnerships.
We strive to deliver high-quality, reliable, and scalable services that enable our clients to bring transformative therapies and scientific breakthroughs to life, ultimately improving global health and well-being.

---

Certifications

---

Activity

• Abs (Antibodies), Peptide, protein, hormone & enzyme, Vaccines, BIOLOGICS, NUTRACEUTICALS, SERVICES manufacturing

---

Features

• Uses: Investigational
• Toxicity (OEB classification):
• DEA: N/A
• BSL: 1, 2
• Therapeutic areas: N/A
• Markets:

---

Batch Size / Reactor

• Small, Batch, Fed-batch, 1 - 100 L

---

Services

• Development services, Analytical / QC services, Downstream, Fill&Finish, Cell line development, Sterile product manufacturing, Non sterile product manufacturing, Upstream

---